Results 171 to 180 of about 2,091,028 (234)

A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial. [PDF]

Nat Commun
Ottensmeier C, Delord JP, Lalanne A, Jamet C, Le Gac AL, Bidet Huang K, Grellier B, Deforges J, Brandely M, Quéméneur E, Bastien B, Tavernaro A, Lacoste G, Schoettel V, Spring-Giusti C, Silvestre N, Marchand JB, Robin S, Dochy E, Ceppi M, Riva A, Yamagata N, Brattas P, Onoguchi K, Yamashita Y, Fontenelle H, Eggert Martinez M, Baker O, Jones T, Schache A, Piaggio E, Bendjama K, Lantz O, Le Tourneau C.   +33 more
europepmc   +1 more source

Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study. [PDF]

Hematol Oncol
Antherieu G, Julia E, Lapierre L, Donzel M, Houillier C, Soussain C, Nicolas-Virelizier E, Rey P, Ducray F, Meyronet D, Picart T, Ysebaert L, Hoang Xuan K, Obéric L, Ghesquières H.   +14 more
europepmc   +1 more source

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia. [PDF]

Leukemia
Oliveira ML, Nuantang K, Huré G, Ávila-Ávila A, Bresson L, Haumont S, Kostova V, Novak T, Le Toumelin-Braizat G, Guerlesquin J, Demarles D, Merdas M, Cauquil N, Goundiam O, Rocchetti F, Courtade-Gaiani S, Valour D, Zerhouni M, Artus R, Douillet-Michel E, Laurent I, Denis A, Ovreiu A, Duvauchelle B, Ecsedi M, Colland F, Geneste O, Maragno AL, Ghysdael J, Tran Quang C.   +29 more
europepmc   +1 more source

Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older - final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE study. [PDF]

Breast
Carola E, Caillet P, Falandry C, Tassy L, Paillaud E, Pulido M, Rochette de Lempdes G, Bringuier M, Jovenin N, Boudrant A, Grosjean J, Chakiba-Brugere C, Guillem O, Hardy Bessard AC, Orfeuvre H, Legouffe E, Brault Y, Chen C, Coumert A, Decrop M, Bouteiller F, Brain E.   +21 more
europepmc   +1 more source

Quantifying cell traction forces at the single-fiber scale in 3D: An approach based on deformable photopolymerized fiber arrays. [PDF]

Proc Natl Acad Sci U S A
Ucla P, Lê-Chesnais J, Ver Hulst H, Ju X, Calvente I, Nematollahi E, Leconte L, Salamero J, Bonnet I, Monnot C, Moreau HD, Landoulsi J, Semetey V, Coscoy S.   +13 more
europepmc   +1 more source

Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21. [PDF]

Blood Neoplasia
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Antunes S, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Levesque Q, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Venditti A, Huls G, EORTC Leukemia Group, Italian Group for Adult Hematologic Diseases, and German MDS Study Group.   +38 more
europepmc   +1 more source

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group. [PDF]

Hemasphere
Sesques P, Manson G, Cartron G, Gros FX, Morschhauser F, Castilla-Llorente C, Brisou G, Bories P, Thieblemont C, Drieu La Rochelle L, Tessoulin B, André A, Rossi C, Paillassa J, Guidez S, Capes A, Herbreteau L, Choquet S, Bay JO, Chauchet A, Lebras L, Claves F, Abraham J, Malfuson JV, Rubio MT, Decroocq J, Fornecker LM, Damaj G, Fouillet L, Joris M, Loschi M, Hermine O, Hafirassou H, Zele EV, Dupont V, Gouill SL, Houot R, Camus V.   +37 more
europepmc   +1 more source

Accelerating real-world data collection using large language models in rare neoplasms: a bone sarcoma example. [PDF]

ESMO Real World Data Digit Oncol
Teterycz P, Rynkun S, Szostakowski B, Wągrodzki M, Rutkowski P, Rosińska M.   +5 more
europepmc   +1 more source

Single-nuclei UPR profiling by flow cytometry reveals bortezomib resistance mechanisms in multiple myeloma. [PDF]

EMBO Mol Med
Gigan JP, Garcia-Gonzalez P, Pilotti A, Galliot L, Reynaud A, Ghaffar Y, Flores-Santibáñez F, Ghafoori S, Seillier E, Lavignolle-Heguy R, Barros D, Bret C, Fichaux S, Combes A, Bani A, Rua R, Gatti E, Nal-Rogier B, Rocchi S, Moreaux J, Pierre P, Argüello RJ.   +21 more
europepmc   +1 more source

Integrating transcriptomic data and artificial intelligence to personalize curative treatments for head and neck cancer patients. [PDF]

NPJ Precis Oncol
Cavalieri S, De Cecco L, Monzani D, Mehanna H, Ferrarotto R, Simon C, Haddad R, Saintigny P, Le Tourneau C, Licitra L.   +9 more
europepmc   +1 more source